glp 1 pittsburgh Weight Loss Services | GLP-1 Medications & Wellness Boosters in 6 delicious and gut-friendly recipes

Alzheimers disease

Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: A retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects

In the Wegovy-pill clinical trial, 18% of people who received the medication discontinued the treatment, which was less than the 26% rate in the placebo group

Because everyone responds differently, setting expectations on GLP-1s means focusing on larger patterns rather than quick results

August 12 Product: Ascendis Pharmas Yorvipath Indication: Hypoparathyroidism After a long regulatory road, Ascendis Pharma received FDA approval Monday for Yorvipath (TransCon PTH) for the treatment of hypoparathyroidism, a rare endocrine disease characterized by abnormally low levels of the parathyroid hormone